Shuttle Pharmaceuticals Holdings Inc (SHPH)
1.87
+0.07
(+3.89%)
USD |
NASDAQ |
Oct 31, 16:00
1.80
-0.07
(-3.74%)
After-Hours: 20:00
Shuttle Pharmaceuticals Holdings Enterprise Value: 3.673M for Oct. 30, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 30, 2024 | 3.673M |
| October 29, 2024 | 3.791M |
| October 28, 2024 | 2.406M |
| October 25, 2024 | 2.170M |
| October 24, 2024 | 2.273M |
| October 23, 2024 | 2.376M |
| October 22, 2024 | 2.671M |
| October 21, 2024 | 2.288M |
| October 18, 2024 | 1.994M |
| October 17, 2024 | 2.052M |
| October 16, 2024 | 1.994M |
| October 15, 2024 | 1.758M |
| October 14, 2024 | 2.088M |
| October 11, 2024 | 1.787M |
| October 10, 2024 | 1.758M |
| October 09, 2024 | 1.522M |
| October 08, 2024 | 1.699M |
| October 07, 2024 | 1.876M |
| October 04, 2024 | 1.920M |
| October 03, 2024 | 1.949M |
| October 02, 2024 | 1.994M |
| October 01, 2024 | 2.052M |
| September 30, 2024 | 2.406M |
| September 27, 2024 | 2.376M |
| September 26, 2024 | 2.465M |
| Date | Value |
|---|---|
| September 25, 2024 | 2.318M |
| September 24, 2024 | 2.494M |
| September 23, 2024 | 2.524M |
| September 20, 2024 | 2.789M |
| September 19, 2024 | 3.260M |
| September 18, 2024 | 2.184M |
| September 17, 2024 | 2.318M |
| September 16, 2024 | 2.229M |
| September 13, 2024 | 2.274M |
| September 12, 2024 | 2.051M |
| September 11, 2024 | 1.694M |
| September 10, 2024 | 1.717M |
| September 09, 2024 | 1.694M |
| September 06, 2024 | 2.118M |
| September 05, 2024 | 3.320M |
| September 04, 2024 | 3.766M |
| September 03, 2024 | 3.33M |
| August 30, 2024 | 2.562M |
| August 29, 2024 | 2.383M |
| August 28, 2024 | 2.436M |
| August 27, 2024 | 3.027M |
| August 26, 2024 | 3.732M |
| August 23, 2024 | 3.364M |
| August 22, 2024 | 3.006M |
| August 21, 2024 | 2.668M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
0.7714M
Minimum
Sep 27 2023
697.25M
Maximum
Sep 01 2022
18.66M
Average
4.572M
Median
Jun 06 2024
Enterprise Value Benchmarks
| Oragenics Inc | 2.027M |
| Soligenix Inc | 1.771M |
| Tonix Pharmaceuticals Holding Corp | 7.710M |
| Lixte Biotechnology Holdings Inc | 5.696M |
| NovaBay Pharmaceuticals Inc | 3.627M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -2.031M |
| Total Expenses (Quarterly) | 1.483M |
| EPS Diluted (Quarterly) | -0.96 |
| Earnings Yield | -186.1% |